Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
British Journal of Cancer|December 1, 2017
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancerShigeki Nanjo, Akito Hata, Chiyuki Okuda, et al.Oncotarget|January 27, 2018
Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Shigeki Nanjo, et al.Anticancer Research|May 13, 2015
A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapyJumpei Takeshita, Katsuhiro Masago, Ryoji Kato, et al.Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Shigeki Nanjo, et al.BMC Cancer|November 18, 2015
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutationsKatsuhiro Masago, Shiro Fujita, Miho Muraki, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2018
Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapyKei Irie, Akira Okada, Yoshio Masuda, et al.Cancer Chemotherapy and Pharmacology|June 18, 2011
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.Journal of Child Neurology|June 1, 2005
Neurophysiologic findings of neuronal migration disorders: intrinsic epileptogenicity of focal cortical dysplasia on electroencephalography, electrocorticography, and magnetoencephalographyHiroshi Otsubo, Koji Iida, Makoto Oishi, et al.Oncology|March 25, 2011
Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinibKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.Lung Cancer (Amsterdam, Netherlands)|June 22, 2015
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)Kazumi Nishino, Fumio Imamura, Toru Kumagai, et al.Pageof 3